Figure 4.

Postoperative overall survival rate of patients with HCC. The comparison shown is according to the MVD determined with an anti-CD105 mAb A or an anti-CD34 mAb B.

Yang et al. BMC Cancer 2006 6:110   doi:10.1186/1471-2407-6-110
Download authors' original image